次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

印刷用表示 |テキストサイズ　小 |中 |大 |

LinkIconHOME
LinkIcon市場調査レポート
LinkIconカスタムリサーチ
LinkIconニュース配信
LinkIcon会社概要
LinkIconLink

創薬における人工知能(AI)の世界市場：技術別、用途別2024年予測

Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024

出版元：MarketsandMarketsLinkIcon出版元について
発行年：2019年11月
定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文156ページになります。
商品コード：MAM1752

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
創薬における人工知能(AI)市場は急速な成長が見込まれ、その世界市場規模は2019年段階の2億5900万ドルから、2024年には14億3400万ドルに達すると予測されます。当レポートでは、2024年に至る創薬における人工知能(AI)の世界市場予測(市場規模US$)、オファリング別市場(ソフトウェア、サービス)、技術別市場(機械学習各種、その他)、用途別市場(がん免疫療法、神経変性疾患、心血管疾患、代謝疾患、その他)、エンドユーザー別市場(製薬/バイオテクノロジー企業、CRO、研究センター/学術および政府機関)、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業20社プロフィール動向などの情報も交えて、創薬における人工知能(AI)市場の現在と今後展開を予測分析していきます。

【レポート構成概要】
◆創薬における人工知能(AI)の世界市場予測2017-2024年
・市場規模(US$)

◆オファリング別、市場-2024年
・ソフトウェア
・サービス
※(市場規模US$)

◆技術別、市場-2024年
機械学習
・深層学習
・教師あり学習
・強化学習
・教師なし学習
・その他機械学習

その他技術

※(市場規模US$)

◆用途別、市場-2024年
・がん免疫療法
・神経変性疾患
・心血管疾患
・代謝疾患
・その他
※(市場規模US$)

◆エンドユーザー別、市場-2024年
・製薬/バイオテクノロジー企業
・医薬品開発業務受託機関(CRO)
・研究センター/学術および政府機関
※(市場規模US$)

◆主要国地域別市場-2024年
北米
・米国、カナダ、メキシコ
欧州
・英国、ドイツ、フランス、
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※国地域別に全てのセグメントの細分化データ掲載、詳細は目次参照
※(市場規模US$)

◆市場分析
・市場ダイナミクス（ドライバー、機会、課題）
・市場シェア分析
・競合状況

◆創薬における人工知能(AI)の主要企業プロフィール動向
・MICROSOFT CORPORATION
・NVIDIA CORPORATION
・IBM CORPORATION
・GOOGLE (A SUBSIDIARY OF ALPHABET INC.)
・ATOMWISE, INC.
・DEEP GENOMICS
・CLOUD PHARMACEUTICALS, INC.
・INSILICO MEDICINE
・BENEVOLENTAI
・EXSCIENTIA
・CYCLICA
・BIOAGE
・NUMERATE
・NUMEDII, INC.
・ENVISAGENICS
・TWOXAR, INCORPORATED
・OWKIN, INC.
・XTALPI, INC.
・VERGE GENOMICS
・BERG LLC

（全156頁）


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.3            MARKET SCOPE
1.3.1               MARKETS COVERED.. 18
1.3.2               YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY
1.5            LIMITATIONS
1.6            STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH DATA
2.1.1               SECONDARY SOURCES. 22
2.1.1.1             KEY DATA FROM SECONDARY SOURCES
2.1.2               PRIMARY SOURCES. 23
2.1.2.1             KEY DATA FROM PRIMARY SOURCES
2.1.2.2             KEY INDUSTRY INSIGHTS
2.2            MARKET SIZE ESTIMATION
2.3            MARKET BREAKDOWN AND DATA TRIANGULATION
2.4            ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET OVERVIEW
4.2            ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING (2019–2024)
4.3            ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE & REGION (2018)
4.4            ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1               MARKET DRIVERS
5.2.1.1             GROWING NUMBER OF CROSS-INDUSTRY COLLABORATIONS AND PARTNERSHIPS. 40
5.2.1.2             NEED TO CONTROL DRUG DISCOVERY & DEVELOPMENT COSTS AND REDUCE TIME
5.2.1.3             PATENT EXPIRY
5.2.2               MARKET OPPORTUNITIES
5.2.2.1             GROWING BIOTECHNOLOGY INDUSTRY
5.2.2.2             EMERGING MARKETS
5.2.3               MARKET CHALLENGES. 42
5.2.3.1             LIMITED AVAILABILITY OF DATA SETS

6.... ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING

6.1            INTRODUCTION
6.2            SOFTWARE
6.2.1               BENEFITS OFFERED BY SOFTWARE IN DRUG DISCOVERY & STRONG DEMAND AMONG END USERS ARE DRIVING MARKET GROWTH
6.3            SERVICES
6.3.1               SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

7.... ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

7.1            INTRODUCTION
7.2            MACHINE LEARNING
7.2.1               INCREASING ADOPTION OF ML BY RESEARCH CENTERS & PHARMACEUTICAL COMPANIES TO SUPPORT THE GROWTH OF THIS SEGMENT
7.2.2               DEEP LEARNING
7.2.3               SUPERVISED LEARNING
7.2.4               REINFORCEMENT LEARNING
7.2.5               UNSUPERVISED LEARNING
7.2.6               OTHER MACHINE LEARNING TECHNOLOGIES
7.3            OTHER TECHNOLOGIES

8.... ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION

8.1            INTRODUCTION
8.2            IMMUNO-ONCOLOGY
8.2.1               HIGH PREVALENCE OF CANCER AND SHORTAGE IN THE SUPPLY OF CANCER DRUGS ARE THE KEY FACTORS DRIVING MARKET GROWTH
8.3            NEURODEGENERATIVE DISEASES
8.3.1               AI IS BEING USED TO RESOLVE EXISTING CHALLENGES IN NEUROLOGICAL DISEASE DRUG DEVELOPMENT
8.4            CARDIOVASCULAR DISEASES
8.4.1               RISING DEMAND FOR CVD DRUGS IS DRIVING MARKET GROWTH
8.5            METABOLIC DISEASES
8.5.1               ROLE OF AI IN UNCOVERING SMALL-MOLECULE THERAPIES IS DRIVING ITS ADOPTION IN THIS SEGMENT
8.6            OTHER APPLICATIONS

9.... ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER

9.1            INTRODUCTION
9.2            PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1               RISING DEMAND FOR SOLUTIONS TO CUT TIME AND COSTS OF DRUG DEVELOPMENT HAVE DRAWN END-USER ATTENTION TO AI
9.3            CONTRACT RESEARCH ORGANIZATIONS
9.3.1               GROWING TREND OF OUTSOURCING PROVIDES SIGNIFICANT OPPORTUNITIES FOR CROS
9.4            RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
9.4.1               THIS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

10.. ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION

10.1          INTRODUCTION
10.2          NORTH AMERICA
10.2.1.1           US
10.2.1.1.1           STRONG ECONOMY AND TREND OF EARLY ADOPTION OF TECHNOLOGIES ARE DRIVING MARKET GROWTH IN THE US
10.2.1.2           CANADA
10.2.1.2.1           GROWING RESEARCH ON AI TECHNOLOGIES AND EMERGENCE OF NEW AI-BASED START-UPS WILL SUPPORT THE MARKET IN CANADA
10.2.1.3           MEXICO
10.2.1.3.1           GOVERNMENT INITIATIVES WILL SUPPORT MARKET GROWTH IN MEXICO
10.3          EUROPE
10.3.1             UK
10.3.1.1           THE UK HOLDS THE LARGEST SHARE OF THE EUROPEAN MARKET
10.3.2             GERMANY
10.3.2.1           GOVERNMENT SUPPORT AND FAVORABLE TRAINING PROGRAMS ARE MAJOR MARKET DRIVERS IN GERMANY
10.3.3             FRANCE
10.3.3.1           STRONG GOVERNMENT SUPPORT AND FAVORABLE STRATEGIES & INITIATIVES FORM KEY DRIVERS OF THE MARKET IN FRANCE
10.3.4             REST OF EUROPE
10.4          ASIA PACIFIC
10.4.1             JAPAN
10.4.1.1           JAPAN DOMINATES THE APAC MARKET FOR AI IN DRUG DISCOVERY
10.4.2             CHINA
10.4.2.1           GROWING CMOS MARKET AND CROSS-INDUSTRY COLLABORATIONS ARE FACTORS RESPONSIBLE FOR THE GROWTH OF THE MARKET IN CHINA
10.4.3             INDIA
10.4.3.1           STEADY ADOPTION OF AI TECHNOLOGIES WILL DRIVE MARKET GROWTH IN INDIA
10.4.4             REST OF ASIA PACIFIC
10.5          REST OF THE WORLD

11.. COMPETITIVE LANDSCAPE

11.1          OVERVIEW
11.2          MARKET SHARE ANALYSIS
11.3          COMPETITIVE LEADERSHIP MAPPING
11.3.1             VISIONARY LEADERS. 117
11.3.2             DYNAMIC DIFFERENTIATORS
11.3.3             INNOVATORS
11.3.4             EMERGING COMPANIES
11.4          COMPETITIVE SITUATION AND TRENDS
11.4.1             PRODUCT LAUNCHES AND ENHANCEMENTS
11.4.2             EXPANSIONS
11.4.3             ACQUISITIONS
11.4.4             OTHER STRATEGIES. 120

12.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
12.1          MICROSOFT CORPORATION
12.2          NVIDIA CORPORATION
12.3          IBM CORPORATION
12.4          GOOGLE (A SUBSIDIARY OF ALPHABET INC.)
12.5          ATOMWISE, INC.
12.6          DEEP GENOMICS
12.7          CLOUD PHARMACEUTICALS, INC.
12.8          INSILICO MEDICINE
12.9          BENEVOLENTAI
12.10       EXSCIENTIA
12.11       CYCLICA
12.12       BIOAGE
12.13       NUMERATE
12.14       NUMEDII, INC.
12.15       ENVISAGENICS
12.16       TWOXAR, INCORPORATED
12.17       OWKIN, INC.
12.18       XTALPI, INC.
12.19       VERGE GENOMICS
12.20       BERG LLC
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

13.. APPENDIX


LIST OF TABLES

TABLE 1               INDICATIVE LIST OF COLLABORATIONS AND PARTNERSHIPS (2017–2019)
TABLE 2               INDICATIVE LIST OF DRUGS LOSING PATENT IN 2019
TABLE 3               ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING,
2017–2024 (USD MILLION)
TABLE 4               ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE,
BY REGION, 2017–2024 (USD MILLION)
TABLE 5               NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 6               EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7               APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8               ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES,
BY REGION, 2017–2024 (USD MILLION)
TABLE 9               NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 13             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2017–2024 (USD MILLION)
TABLE 14             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY REGION, 2017–2024 (USD MILLION)
TABLE 15             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING,
BY REGION, 2017–2024 (USD MILLION)
TABLE 19             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY REGION, 2017–2024 (USD MILLION)
TABLE 23             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET
FOR SUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 24             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 26             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2017–2024 (USD MILLION)
TABLE 27             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 29             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2017–2024 (USD MILLION)
TABLE 31             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 32             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 35             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET
FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 36             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 39             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET
FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 40             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 41             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 42             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 43             INDICATIVE LIST OF INITIATIVES IN IMMUNO-ONCOLOGY DRUG DEVELOPMENT
TABLE 44             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNO-ONCOLOGY, BY REGION, 2017–2024 (USD MILLION)
TABLE 45             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNO-ONCOLOGY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR
IMMUNO-ONCOLOGY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 47             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR
IMMUNO-ONCOLOGY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 48             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2017–2024 (USD MILLION)
TABLE 49             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 50             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 51             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 52             INDICATIVE LIST OF DEVELOPMENTS IN CARDIOVASCULAR DRUG DEVELOPMENT
TABLE 53             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2017–2024 (USD MILLION)
TABLE 54             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 55             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 56             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 57             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY REGION, 2017–2024 (USD MILLION)
TABLE 58             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 59             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 60             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 61             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 62             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 63             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 64             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 65             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 66             INDICATIVE LIST OF DEVELOPMENTS
TABLE 67             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 68             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 69             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 70             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 71             INDICATIVE LIST OF COLLABORATIONS WITH CROS
TABLE 72             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 73             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 74             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 75             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 76             INDICATIVE LIST OF RESEARCH COLLABORATIONS
TABLE 77             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR RESEARCH
CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION,
2017–2024 (USD MILLION)
TABLE 78             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET
FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES,
2017–2024 (USD MILLION)
TABLE 79             EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR
RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES,
2017–2024 (USD MILLION)
TABLE 80             APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR
RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES,
2017–2024 (USD MILLION)
TABLE 81             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 82             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 83             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY OFFERING, 2017–2024 (USD MILLION)
TABLE 84             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 85             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 86             NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY END USER, 2017–2024 (USD MILLION)
TABLE 87             INDICATIVE LIST OF STRATEGIC DEVELOPMENTS
TABLE 88             US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 89             US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 90             US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 91             US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 92             CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 93             CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 94             CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 95             CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 96             MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 97             MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 98             MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 99             MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY END USER, 2017–2024 (USD MILLION)
TABLE 100          EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 101          EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY OFFERING, 2017–2024 (USD MILLION)
TABLE 102          EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 103          EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 104          EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY END USER, 2017–2024 (USD MILLION)
TABLE 105          INDICATIVE LIST OF STRATEGIC DEVELOPMENTS
TABLE 106          UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 107          UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 108          UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 109          UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 110          GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY OFFERING, 2017–2024 (USD MILLION)
TABLE 111          GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 112          GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 113          GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY END USER, 2017–2024 (USD MILLION)
TABLE 114          FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY OFFERING, 2017–2024 (USD MILLION)
TABLE 115          FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 116          FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 117          FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 118          ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 119          ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 120          ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 121          ROE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 122          APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 123          APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 124          APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 125          APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 126          APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 127          JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 128          JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 129          JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 130          JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 131          CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 132          CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 133          CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 134          CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 135          INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 136          INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 137          INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 138          INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 139          ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 140          ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 141          ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET,
BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 142          ROAPAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 143          ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017–2024 (USD MILLION)
TABLE 144          ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 145          ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 146          ROW: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 147          PRODUCT LAUNCHES AND ENHANCEMENTS, 2016–2019
TABLE 148          EXPANSIONS, 2016–2019
TABLE 149          ACQUISITIONS, 2016–2019
TABLE 150          OTHER STRATEGIES, 2016–2019

 

LIST OF FIGURES

FIGURE 1             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY: MARKET SEGMENTATION
FIGURE 2             RESEARCH DESIGN
FIGURE 3             BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 4             BOTTOM-UP APPROACH
FIGURE 5             TOP-DOWN APPROACH
FIGURE 6             DATA TRIANGULATION METHODOLOGY
FIGURE 7             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING,
2019 VS. 2024 (USD MILLION)
FIGURE 8             ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2019–2024
FIGURE 9             ARTIFICIAL LEARNING IN DRUG DISCOVERY MARKET, BY APPLICATION,
2019 VS. 2024 (USD MILLION)
FIGURE 10          ARTIFICIAL LEARNING IN DRUG DISCOVERY MARKET, BY END USER,
2019 VS. 2024 (USD MILLION)
FIGURE 11          GEOGRAPHICAL SNAPSHOT OF THE ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET  34
FIGURE 12          NEED TO CONTROL DRUG DISCOVERY & DEVELOPMENT COSTS IS A MAJOR FACTOR DRIVING THE ADOPTION OF AI IN DRUG DISCOVERY SOLUTIONS
FIGURE 13          SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD
FIGURE 14          DEEP LEARNING SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE
IN 2018
FIGURE 15          NORTH AMERICA IS THE FASTEST-GROWING REGIONAL MARKET FOR AI
IN DRUG DISCOVERY
FIGURE 16          ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17          NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY
MARKET SNAPSHOT
FIGURE 18          EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SNAPSHOT
FIGURE 19          KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES
FIGURE 20          MARKET EVOLUTION FRAMEWORK
FIGURE 21          AI IN DRUG DISCOVERY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
FIGURE 22          COMPETITIVE LEADERSHIP MAPPING OF THE AI IN DRUG DISCOVERY MARKET
FIGURE 23          MICROSOFT CORPORATION: COMPANY SNAPSHOT
FIGURE 24          NVIDIA CORPORATION: COMPANY SNAPSHOT
FIGURE 25          IBM CORPORATION: COMPANY SNAPSHOT
FIGURE 26          ALPHABET: COMPANY SNAPSHOT


掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

▲　ページトップへ

LinkIconリサーチカテゴリ一覧
LinkIconスマートグリッド
LinkIcon電池・燃料電池・蓄電池
LinkIcon再生可能エネルギー
LinkIcon天然資源・エネルギー
LinkIconマテリアル
LinkIcon水処理・水資源
LinkIcon航空宇宙・防衛セキュリティ
LinkIcon自動車・各種車両
LinkIcon通信・IT
LinkIcon消費財・食品飲料
LinkIcon医療・医薬品・ヘルスケア
LinkIcon電気・エレクトロニクス
LinkIcon産業機械、マシナリー

関連レポート

LinkIcon医療ヘルスケア向け人工知能(AI)の世界市場：2025年に至る用途別、技術別予測

LinkIcon

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
（ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません）

お問い合わせ

LinkIconお問合わせはこちらから

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。


milk_btn_pagetop.png

since 2009-08-17 / Copyright 2016 ResearchStation, LLC. All Rights Reserved.